跳至主要内容
临床试验/IRCT20210607051507N3
IRCT20210607051507N3招募中3 期

Early use of Acetazolamide to prevent progression of Intraventricular hemorrhage in preterm newborns - A Double-Blind Randomized Clinical Trial

Tehran University of Medical Sciences0 个研究点目标入组 132 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
132

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • All infants admitted to the neonatal intensive care unit at Shariati and Imam Khomeini Hospitals in Tehran under the age of 34 weeks or weighing less than 1700 g in 2020-2021
  • According to the brain ultrasound performed, they have intraventricular hemorrhage of grade two and above

排除标准

  • Syndromic cases
  • cases with genetic diseases
  • infants with metabolic and neuromuscular diseases
  • cyanotic heart disease
  • necrotizing enterocolitis
  • gastrointestinal bleeding

研究者

相似试验